Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
Blood
; 101(1): 64-70, 2003 Jan 01.
Article
em En
| MEDLINE
| ID: mdl-12393605
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Crise Blástica
/
Leucemia Mieloide
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article